Innovation Institute Blog

McGowan Institute Generating Translational Track Record of Success

The Pitt McGowan Institute for Regenerative Medicine has racked up some impressive numbers in its 25-year existence. Researchers affiliated with McGowan have had 140 patents issued, filed more than 900 invention disclosures; had their technology licensed more than 170 times and have spun out nearly 30 companies from the University. We sat down with McGowan's director since 2011, William Wagner, to discuss the reasons behind its success and what exciting things are happening in its labs that are changing the way patients are treated for a wide range of diseases and injuries.
Read More

5 Reasons to Attend the @PittInnovates Open

Read More

Big Things Can Happen When Your Idea Gets Oxygen

Blake Dube's transformation from undergraduate engineering student into CEO of his own company, Aeronics, happened in a rapid-fire manner when he and fellow students Mark Spitz and Alec Kaija were encouraged by their professors to explore the commercial potential of their research. They took full advantage of the programs and resources available through the Innovation Institute and its Big Idea Center for student entrepreneurship. Aeronics won prizes in the Randall Family Big Idea Competition, the Michael G. Wells Healthcare competition, the Kuzneski Innovation Cup. They participated in the Blast Furnace accelerator and received guidance and support from several mentors and entrepreneurs in residence. They also received support from the greater Pitt innovation ecosystem, including winning a prize in the Pitt Innovation Challenge (PInCh).
Read More

Stopping a Silent Killer

Pitt smashed its record for startups in Fiscal 2018, which concludes today.  (Final numbers for the year will be reported next month.) One of the driving factors for the increase in startup activity is an evolution in policy at the university making it possible for faculty to take positions within a startup. Today we  catch up with Globin Solutions, a recent startup formed from research from the lab of Dr. Mark Gladwin, led by Jason Rose, an assistant professor, who is the new company's CEO.
Read More

Pitt Biotech Spinout Oncorus Works Toward Clinical Trials

At the recent annual BIO International Convention, more than 18,000 attendees converged on Boston to chart the biotech industry’s future and hold nearly 47,000 partnering meetings, a certified world record. The Innovation Institute was on hand to showcase its portfolio of life science discoveries available for licensing and to seek potential partnerships with industry, entrepreneurs and investors. Once again, the red hot field of cancer immunotherapy was front and center in a lot of the discussions. While in Boston, we took the opportunity to visit Pitt spinout, Oncorus, which is developing therapies in the emerging oncolytic virus domain of immunotherapy, to get an update on the company’s progress.
Read More